VBLT - VBL Therapeutics EPS beats by $0.01 misses on revenue November, 16 2020 07:04 AM Vascular Biogenics Ltd. VBL Therapeutics (VBLT): Q3 GAAP EPS of -$0.12 beats by $0.01.Revenue of $0.19M (+137.5% Y/Y) misses by $0.01M.Press Release For further details see: VBL Therapeutics EPS beats by $0.01, misses on revenue